The Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Nat Rev Nephrol. 2010 Oct;6(10):577-83. doi: 10.1038/nrneph.2010.101. Epub 2010 Aug 3.
Several types of T cells with immunosuppressive properties have been identified, but FOXP3(+) regulatory T (T(REG)) cells have emerged as a dominant cell type; they are critically involved in the induction and maintenance of immune tolerance. Manipulation of this cell type for the induction of transplant tolerance including renal transplant tolerance has attracted considerable attention. Studies in this area have demonstrated unexpected complexities, and attempts to translate T(REG) cells towards clinical utility have met with unanticipated difficulties. In this Review, a broad overview is provided on recent progress in the study of T(REG) cells, focusing on challenges, opportunities, and emerging approaches in exploiting T(REG) cells for the induction of transplant tolerance.
已经鉴定出几种具有免疫抑制特性的 T 细胞,但 FOXP3(+)调节性 T(TREG)细胞已成为主要的细胞类型;它们在诱导和维持免疫耐受中起着至关重要的作用。对这种细胞类型进行操作以诱导包括肾移植耐受在内的移植耐受已引起广泛关注。该领域的研究表明存在意想不到的复杂性,并且尝试将 TREG 细胞转化为临床应用也遇到了意想不到的困难。在这篇综述中,对 TREG 细胞研究的最新进展进行了广泛概述,重点介绍了利用 TREG 细胞诱导移植耐受所面临的挑战、机遇和新方法。